|
Kwality Pharmaceuticals Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
1001.67 Cr.
|
P/BV
|
4.16
|
Book Value (Rs.)
|
232.30
|
|
52 Week High/Low (Rs.)
|
1235/596
|
FV/ML
|
10/1
|
P/E(X)
|
25.14
|
|
Bookclosure
|
24/09/2024
|
EPS (Rs.)
|
38.40
|
Div Yield (%)
|
0.03
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 370.20 | 307.17 | 251.03 | 456.19 | 262.01 |
| Total Operating Revenues | 370.20 | 307.17 | 251.03 | 456.19 | 262.01 |
| | | | | | |
| Other Income | 1.92 | 1.83 | 2.94 | 3.51 | 1.59 |
| Total Revenue | 372.12 | 309.00 | 253.97 | 459.70 | 263.60 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 165.41 | 153.81 | 113.22 | 199.31 | 165.28 |
| Purchase Of Stock-In Trade | 15.90 | 0.85 | 0.04 | 3.80 | 0.22 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 1.17 | -1.48 | -3.20 | -2.51 | 0.09 |
| Employee Benefit Expenses | 43.78 | 32.56 | 29.96 | 20.15 | 15.90 |
| Finance Costs | 9.88 | 10.39 | 6.02 | 2.92 | 2.67 |
| Depreciation And Amortisation Expenses | 18.29 | 19.56 | 14.96 | 10.69 | 6.49 |
| Other Expenses | 63.54 | 55.11 | 50.86 | 63.77 | 51.67 |
| Total Expenses | 317.98 | 270.80 | 211.87 | 298.13 | 242.33 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 54.14 | 38.20 | 42.10 | 161.57 | 21.27 |
| | | | | | |
| Exceptional Items | 0.00 | -7.10 | -16.53 | 0.00 | 0.00 |
| Profit/Loss Before Tax | 54.14 | 31.10 | 25.57 | 161.57 | 21.27 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 14.69 | 7.92 | 6.48 | 41.00 | 5.80 |
| Deferred Tax | -1.59 | -0.44 | 0.14 | 0.27 | 0.16 |
| Tax For Earlier Years | 1.23 | 0.00 | -0.33 | 0.35 | 0.42 |
| Total Tax Expenses | 14.34 | 7.48 | 6.29 | 41.63 | 6.38 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 39.80 | 23.62 | 19.28 | 119.94 | 14.89 |
| | | | | | |
| Profit/Loss From Continuing Operations | 39.80 | 23.62 | 19.28 | 119.94 | 14.89 |
| | | | | | |
| Profit/Loss For The Period | 39.80 | 23.62 | 19.28 | 119.94 | 14.89 |
| | | | | | |
| Minority Interest | 0.04 | 0.18 | 0.09 | 0.05 | 0.26 |
| Consolidated Profit/Loss After MI And Associates | 39.85 | 23.80 | 19.37 | 119.99 | 15.15 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 38.36 | 22.76 | 18.16 | 115.64 | 14.60 |
| Diluted EPS (Rs.) | 38.36 | 22.76 | 18.16 | 115.64 | 14.60 |
